Search
CELL BANK Website

Back Back
Cell No. : Cell Name
RCB2136 : YST-1  update : 2024/08/14
CommentHuman cell line derived from schwannoma. TKG0454 (Deposited from Tohoku Univ.).
Comment from the depositor
Terms and conditionsA prior written permission of the approver(Originator) is necessary for any kind of use including academic use and for-profit use.
Remarks
approver's address
×
English
Address
Tokyo women's medical university hospital
Depatment of Surgery Pathology
8-1,Kawada-cho,Sinjuku,Tokyo 162-8666 Japan
Dr.NAGASHIMA Yoji
Fax. +81-3-5269-7358
Order Form Order Form(C-0005.pdf)   Approval Form(C-0006.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
Basic information Depositor Obinata, Masuo
Originator Nagashima, Yoji
Year of deposit 2005
Original cell TKG0454
Animal _human < Mammals
Genus Homo
Species sapiens
Gender Female
Age at sampling 8 years
Tissue right arm
Disease name malignant schwannoma
Classification cancer
History Cell Resource Center for Biomedical Research, Tohoku University（TKG0454）
Lifespan infinite
Morphology other
Cellosaurus(Expasy) CVCL_5192
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Culture medium RPMI1640 + 10% FBS
Antibiotics Free
Passage method pipetting or 0.25% Trypsin (<1min.)
Culture information Passage ratio 1 : 8 split
SC frequency Subculture : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma/Acholeplasma (-)
Isozyme LD, NP
STR(human) OK
Images
deposit info
lot info
Reference information Reference 0
User's Publication 6


To topTop
Reference

To topTop
User's Publication
21401  Yamamuro-Tanabe A, Kosuge Y, Ishimaru Y, Yoshioka Y.  Schwann cell derived-peroxiredoxin protects motor neurons against hydrogen peroxide-induced cell death in mouse motor neuron cell line NSC-34.  J Pharmacol Sci  2023  153(2)73-83  PubMed ID: 37640472   DOI: 10.1016/j.jphs.2023.07.006
13106  Itoyama T, Yoshida S, Tomokiyo A, Hasegawa D, Hamano S, Sugii H, Ono T, Fujino S, Maeda H.  Possible function of GDNF and Schwann cells in wound healing of periodontal tissue.  J Periodontal Res  2020    PubMed ID: 32562261   DOI: 10.1111/jre.12774
14763  Kolberg M, Bruun J, Murumägi A, Mpindi JP, Bergsland CH, Høland M, Eilertsen IA, Danielsen SA, Kallioniemi O, Lothe RA.  Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors  Mol Oncol  2017  11(9):1156-1171  PubMed ID: 28556483   DOI: 10.1002/1878-0261.12086
17972  Endo M, Yamamoto H, Setsu N, Kohashi K, Takahashi Y, Ishii T, Iida K, Matsumoto Y, Hakozaki M, Aoki M, Iwasaki H, Dobashi Y, Nishiyama K, Iwamoto Y, Oda Y.  Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors  Clin Cancer Res  2013  19(2):450-61  PubMed ID: 23209032   DOI: 10.1158/1078-0432.CCR-12-1067
17973  Itani S, Kunisada T, Morimoto Y, Yoshida A, Sasaki T, Ito S, Ouchida M, Sugihara S, Shimizu K, Ozaki T.  MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4)  J Cancer Res Clin Oncol  2012  138(9):1501-9  PubMed ID: 22526161   DOI: 10.1007/s00432-012-1223-1
8364  Wakao S, Hayashi T, Kitada M, Kohama M, Matsue D, Teramoto N, Ose T, Itokazu Y, Koshino K, Watabe H, Iida H, Takamoto T, Tabata Y, Dezawa M.  Long-term observation of auto-cell transplantation in non-human primate reveals safety and efficiency of bone marrow stromal cell-derived Schwann cells in peripheral nerve regeneration.  Exp. Neurol.  2010  223:537-47  PubMed ID: 20153320   DOI: 10.1016/j.expneurol.2010.01.022


Back Back Return Top Page